[Treatment of hormone-refractory prostate cancer with etoposide (Vp16)].
Nagayama
T
T
Division of Urology, Chiba Cancer Center Hospital.
Maruoka
M
M
D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D005047:Etoposide / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide